Allergic individuals at risk for hypersensitivity reactions to measles vaccine marketed for a long time are well established. On the other hand, risk factors for hypersensitivity reactions to the new mRNA COVID-19 vaccines currently include a history of allergy, allergy to excipient of the vaccine, or hypersensitivity reactions to the first dose of COVID-19 vaccine. In the last two cases, the recipient should be assessed by an allergist before vaccination to share a decision on the choice of vaccination. Studies on skin testing accuracy and desensitization protocols to the COVID-19 vaccines and the efficacy of potential alternatives in patients with confirmed hypersensitivity reactions to the first COVID-19 vaccine are necessary to improve the safety of COVID-19 vaccines.

Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2 / Caffarelli, C.; Liotti, L.; Bianchi, A.; Bottau, P.; Caimmi, S.; Crisafulli, G.; Franceschini, F.; Paglialunga, C.; Saretta, F.; Mori, F.. - In: PEDIATRIC ALLERGY AND IMMUNOLOGY. - ISSN 0905-6157. - 33:27(2022), pp. 58-60. [10.1111/pai.13631]

Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2

Caffarelli C.
;
2022-01-01

Abstract

Allergic individuals at risk for hypersensitivity reactions to measles vaccine marketed for a long time are well established. On the other hand, risk factors for hypersensitivity reactions to the new mRNA COVID-19 vaccines currently include a history of allergy, allergy to excipient of the vaccine, or hypersensitivity reactions to the first dose of COVID-19 vaccine. In the last two cases, the recipient should be assessed by an allergist before vaccination to share a decision on the choice of vaccination. Studies on skin testing accuracy and desensitization protocols to the COVID-19 vaccines and the efficacy of potential alternatives in patients with confirmed hypersensitivity reactions to the first COVID-19 vaccine are necessary to improve the safety of COVID-19 vaccines.
Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2 / Caffarelli, C.; Liotti, L.; Bianchi, A.; Bottau, P.; Caimmi, S.; Crisafulli, G.; Franceschini, F.; Paglialunga, C.; Saretta, F.; Mori, F.. - In: PEDIATRIC ALLERGY AND IMMUNOLOGY. - ISSN 0905-6157. - 33:27(2022), pp. 58-60. [10.1111/pai.13631]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2933806
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact